title: [Gastric adenocarcinoma secondary to Hodgkin's disease treatment].
abstract: Second malignant neoplasms are a major cause of late morbidity and mortality following treatment for Hodgkin's disease. Gastric carcinoma belong to the rare secondary malignancies induced by radiation-therapy and it is associated with a poor prognosis. We report a patient treated for Hodgkin's disease by 6 ABVD and total lymphoid radiation therapy, who developed a gastric carcinoma 9 years after completing treatment. Our case fits the criteria for radiation induced malignancies reported from the literature:
  
  
  CONCLUSIONS
  recommendations are presented for both prevention and early detection of the tumours we recommend a strict follow-up for patients treated for HD to detect second cancers.
authors.affiliation: Service d'Hématologie Clinique, CHU Farhat Hached de Sousse.
authors.forename: H
authors.initials: H
authors.lastname: el Omri
authors.forename: B
authors.initials: B
authors.lastname: Sriha
authors.forename: I
authors.initials: I
authors.lastname: Kraiem
authors.forename: Y B
authors.initials: YB
authors.lastname: Youssef
authors.forename: H
authors.initials: H
authors.lastname: Skouri
authors.forename: S
authors.initials: S
authors.lastname: Korbi
authors.forename: S
authors.initials: S
authors.lastname: Ennabli
mesh_terms: D000230:Adenocarcinoma / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D000328:Adult; D000359:Aftercare / Q000379:methods; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001706:Biopsy; D001761:Bleomycin / Q000009:adverse effects*; D003606:Dacarbazine / Q000009:adverse effects*; D003680:Deglutition Disorders / Q000209:etiology; D004317:Doxorubicin / Q000009:adverse effects*; D017809:Fatal Outcome; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D013274:Stomach Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000009:adverse effects*; D015431:Weight Loss
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
vernacular_title: Adenocarcinome gastrique secondaire au traitement d'une maladie de Hodgkin.